Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study. The Multi-Ethnic Study of Atherosclerosis

Academic Radiology

Volumn 19, Issue 7, 2012, Pages 811-818

  Zeb, Irfan ^a   Li, Dong ^a   Nasir, Khurram ^b   Katz, Ronit ^c   Larijani, Vahid N ^a   Budoff, Matthew J ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Computed tomography; Fatty liver; MESA

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ASYMPTOMATIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DYSLIPIDEMIA; FATTY LIVER; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SPLEEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862491194     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.02.022     Document Type: Article

References (40)

1. Nonalcoholic fatty liver disease. In: Fauci AS, Braunwald E, Kasper DL, et al, editors. Harrison's Principles of Internal Medicine, 17th ed. USA: McGraw-Hill Companies Inc; 2008. p.1982-1983.
2. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12:1106-1110.
3. Adler M., Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979, 67:811-816.
4. Nasrallah S.M., Wills C.E., Galambos J.T. Hepatic morphology in obesity. Dig Dis Sci 1981, 26:325-327.
5. Clain D.J., Lefkowitch J.H. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987, 16:239-252.
6. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
7. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
8. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
9. Younossi Z.M., Gramlich T., Liu Y.C., et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol 1998, 11:560-565.
10. Hamaguchi M., Kojima T., Takeda N., et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007, 13:1579-1584.
11. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
12. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
13. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
14. Goto T., Onuma T., Takebe K., et al. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995, 19:841-845.
15. Zelber-Sagi S., Nitzan-Kaluski D., Halpern Z., et al. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006, 26:856-863.
16. Lucero D., Zago V., Lopez G.I., et al. Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome. Clin Chim Acta 2011, 412:143-147.
17. Crum-Cianflone N., Krause D., Wessman D., et al. Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*). HIV Med 2011, 12:463-471.
18. Targher G., Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191:235-240.
19. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
20. Bedogni G., Miglioli L., Masutti F., et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysus nutrition and liver study. Hepatology 2005, 42:44-52.
21. Nomura H., Kashiwagi S., Hayashi J., et al. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988, 27(2):142-149.
22. Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003, 98:960-967.
23. Jimba S., Nakagami T., Takahashi M., et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005, 22:1141-1145.
24. Boyce C.J., Pickhardt P.J., Kim D.H., et al. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010, 194:623-628.
25. Lee S.S., Park S.H., Kim H.J., et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010, 52:579-585.
26. Piekarski J., Goldberg H.I., Royal S.A., et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980, 137:727-729.
27. Bydder G.M., Chapman R.W., Harry D., et al. Computed tomography attenuation values in fatty liver. J Comput Tomogr 1981, 5:33-35.
28. Kawata R., Sakata K., Kunieda T., et al. Quantitative evaluation of fatty liver by computed tomography in rabbits. AJR Am J Roentgenol 1984, 142:741-746.
29. Kodama Y., Ng C.S., Wu T.T., et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007, 188:1307-1312.
30. Park S.H., Kim P.N., Kim K.W., et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006, 239:105-112.
31. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871-881.
32. Carr J.J., Nelson J.C., Wong N.D., et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005, 234:35-43.
33. Becker U., Deis A., Sorensen T.I., et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996, 23:1025-1029.
34. Coates R.A., Halliday M.L., Rankin J.G., et al. Risk of fatty infiltration or cirrhosis of the liver in relation to ethanol consumption: a case-control study. Clin Invest Med 1986, 9:26-32.
35. Longo R., Ricci C., Masutti F., et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993, 28:297-302.
36. Pamilo M., Sotaniemi E.A., Suramo I., et al. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol 1983, 18:743-747.
37. Johnston R.J., Stamm E.R., Lewin J.M., et al. Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdom Imaging 1998, 23:409-415.
38. Iwasaki M., Takada Y., Hayashi M., et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004, 78:1501-1505.
39. Speliotes E.K., Massaro J.M., Hoffmann U., et al. Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 2008, 23:894-899.
40. Davidson L.E., Kuk J.L., Church T.S., et al. Protocol for measurement of liver fat by computed tomography. J Appl Physiol 2006, 100:864-868.